The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

Allogene Therapeutics has announced an expanded collaboration with Foresight Diagnostics to develop a minimal residual disease (MRD) assay as a companion diagnostic tool for identifying patients with ...

Advanced technologies are taking in vitro diagnostics (IVD) far beyond lateral flow tests or immunoassays. Molecular technologies like PCR and NGS are rapidly expanding in the diagnostic assay ...

The COVID-19 pandemic and geopolitical conflict in Eastern Europe have done irreparable damage to the underpinnings of the clinical diagnostic industry. These events significantly impacted the supply ...

PHOENIX, Dec. 16, 2025 /PRNewswire/ -- Aces Diagnostics Inc., a biotechnology company dedicated to delivering accurate and accessible diagnostics for Lyme disease, announced significant progress ...

IBL International has entered a strategic collaboration with healthcare company Grifols to develop biomarker panels for speciality diagnostics. Through this partnership, IBL will develop the panels ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. At Illumina’s Genomics Forum conference this fall, former ...

CINCINNATI, July 24, 2023 /PRNewswire/ -- The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced ...